{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:59:27Z","timestamp":1788577167693,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200317"],"award-info":[{"award-number":["82200317"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070316"],"award-info":[{"award-number":["82070316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB891"],"award-info":[{"award-number":["2024AFB891"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06926-0","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:31:39Z","timestamp":1754483499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD36 attenuates pressure overload-induced myocardial insulin resistance via HSF1-dependent HSP90\u03b1 suppression and competitive disruption of the HSP90\u03b1-InsR complex"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongyang","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"6926_CR1","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","volume":"324","author":"JR Baman","year":"2020","unstructured":"Baman JR, Ahmad FS. Heart failure. JAMA. 2020;324:1015.","journal-title":"JAMA"},{"key":"6926_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12967-023-04734-y","volume":"22","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Liu X, Jiang L, Hao T, Wang Y, Li T. Inhibition of ferroptosis reverses heart failure with preserved ejection fraction in mice. J Transl Med. 2024;22:199.","journal-title":"J Transl Med"},{"key":"6926_CR3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513.","journal-title":"Circ Res"},{"key":"6926_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10741-021-10096-8","volume":"27","author":"X Wang","year":"2022","unstructured":"Wang X, Ni J, Guo R, Li L, Su J, He F, Fan G. SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism. Heart Fail Rev. 2022;27:961\u201380.","journal-title":"Heart Fail Rev"},{"key":"6926_CR5","doi-asserted-by":"publisher","first-page":"1416462","DOI":"10.3389\/fendo.2024.1416462","volume":"15","author":"X Su","year":"2024","unstructured":"Su X, Zhao C, Zhang X. Association between METS-IR and heart failure: a cross-sectional study. Front Endocrinol (Lausanne). 2024;15:1416462.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6926_CR6","first-page":"e63","volume":"150","author":"Correction to","year":"2024","unstructured":"Correction to. Nitrative modification of Caveolin-3: a novel mechanism of cardiac insulin resistance and a potential therapeutic target against ischemic heart failure in prediabetic animals. Circulation. 2024;150:e63.","journal-title":"Circulation"},{"key":"6926_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/ejhf.2531","volume":"24","author":"S Erqou","year":"2022","unstructured":"Erqou S, Adler AI, Challa AA, Fonarow GC, Echouffo-Tcheugui JB. Insulin resistance and incident heart failure: a meta-analysis. Eur J Heart Fail. 2022;24:1139\u201341.","journal-title":"Eur J Heart Fail"},{"key":"6926_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","volume":"118","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW. The role of CD36 in cardiovascular disease. Cardiovasc Res. 2022;118:115\u201329.","journal-title":"Cardiovasc Res"},{"key":"6926_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00011.2023","volume":"104","author":"JFC Glatz","year":"2024","unstructured":"Glatz JFC, Heather LC, Luiken J. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiol Rev. 2024;104:727\u201364.","journal-title":"Physiol Rev"},{"key":"6926_CR10","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1038\/s41467-021-23808-3","volume":"12","author":"V Cifarelli","year":"2021","unstructured":"Cifarelli V, Appak-Baskoy S, Peche VS, Kluzak A, Shew T, Narendran R, Pietka KM, Cella M, Walls CW, Czepielewski R, Ivanov S, Randolph GJ, Augustin HG, Abumrad NA. Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells. Nat Commun. 2021;12:3350.","journal-title":"Nat Commun"},{"key":"6926_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2022.05.003","volume":"363","author":"M Chen","year":"2022","unstructured":"Chen M, Bai M, Yi Y, Lu S, Luo J, Li P, Zhang H, Jiang H, Zhou H. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice. Toxicol Lett. 2022;363:1\u201310.","journal-title":"Toxicol Lett"},{"key":"6926_CR12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0140-6736(00)04138-6","volume":"357","author":"K Miyaoka","year":"2001","unstructured":"Miyaoka K, Kuwasako T, Hirano K, Nozaki S, Yamashita S, Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet. 2001;357:686\u20137.","journal-title":"Lancet"},{"key":"6926_CR13","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2337\/dc13-2835","volume":"37","author":"TA Pietka","year":"2014","unstructured":"Pietka TA, Schappe T, Conte C, Fabbrini E, Patterson BW, Klein S, Abumrad NA, Love-Gregory L. Adipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance. Diabetes Care. 2014;37:1990\u20137.","journal-title":"Diabetes Care"},{"key":"6926_CR14","doi-asserted-by":"publisher","first-page":"101255","DOI":"10.1016\/j.molmet.2021.101255","volume":"52","author":"MC Lawrence","year":"2021","unstructured":"Lawrence MC. Understanding insulin and its receptor from their three-dimensional structures. Mol Metab. 2021;52:101255.","journal-title":"Mol Metab"},{"key":"6926_CR15","doi-asserted-by":"publisher","first-page":"10470","DOI":"10.1073\/pnas.0701114104","volume":"104","author":"RR Ramos","year":"2007","unstructured":"Ramos RR, Swanson AJ, Bass J. Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the Endoplasmic reticulum. Proc Natl Acad Sci U S A. 2007;104:10470\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6926_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-020-02777-3","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Deng B, Liu Q, Huang Y, Chen W, Li J, Zhou Z, Zhang L, Liang B, He J, Chen Z, Yan C, Yang Z, Xian S, Wang L. Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis. 2020;11:574.","journal-title":"Cell Death Dis"},{"key":"6926_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12967-023-04163-x","volume":"21","author":"Y Feng","year":"2023","unstructured":"Feng Y, Yuan Y, Xia H, Wang Z, Che Y, Hu Z, Deng J, Li F, Wu Q, Bian Z, Zhou H, Shen D, Tang Q. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM\/LIFR\/STAT3 signalling. J Transl Med. 2023;21:290.","journal-title":"J Transl Med"},{"key":"6926_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00395-020-0787-1","volume":"115","author":"H Jiang","year":"2020","unstructured":"Jiang H, Jia D, Zhang B, Yang W, Dong Z, Sun X, Cui X, Ma L, Wu J, Hu K, Sun A, Ge J. Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression. Basic Res Cardiol. 2020;115:28.","journal-title":"Basic Res Cardiol"},{"key":"6926_CR19","doi-asserted-by":"publisher","first-page":"707399","DOI":"10.3389\/fphar.2021.707399","volume":"12","author":"H Shu","year":"2021","unstructured":"Shu H, Hang W, Peng Y, Nie J, Wu L, Zhang W, Wang DW, Zhou N. Trimetazidine attenuates heart failure by improving myocardial metabolism via AMPK. Front Pharmacol. 2021;12:707399.","journal-title":"Front Pharmacol"},{"key":"6926_CR20","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41401-022-00877-8","volume":"43","author":"HY Shu","year":"2022","unstructured":"Shu HY, Peng YZ, Hang WJ, Zhang M, Shen L, Wang DW, Zhou N. Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter. Acta Pharmacol Sin. 2022;43:2550\u201361.","journal-title":"Acta Pharmacol Sin"},{"key":"6926_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-023-04043-4","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Qin C, Zhao B, Li Z, Li T, Yang X, Zhao Y, Wang W. EGR1 induces EMT in pancreatic cancer via a P300\/SNAI2 pathway. J Transl Med. 2023;21:201.","journal-title":"J Transl Med"},{"key":"6926_CR22","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1038\/s41467-021-24215-4","volume":"12","author":"D Vanhoutte","year":"2021","unstructured":"Vanhoutte D, Schips TG, Vo A, Grimes KM, Baldwin TA, Brody MJ, Accornero F, Sargent MA, Molkentin JD. Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. Nat Commun. 2021;12:3928.","journal-title":"Nat Commun"},{"key":"6926_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-023-04845-6","volume":"22","author":"L Zhang","year":"2024","unstructured":"Zhang L, Zhang X, Liu H, Yang C, Yu J, Zhao W, Guo J, Zhou B, Jiang N. MTFR2-dependent mitochondrial fission promotes HCC progression. J Transl Med. 2024;22:73.","journal-title":"J Transl Med"},{"key":"6926_CR24","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/eurheartj\/ehab651","volume":"43","author":"A Bay\u00e9s-Gen\u00eds","year":"2022","unstructured":"Bay\u00e9s-Gen\u00eds A, D\u00edez J. Transition to heart failure in hypertension: going to the heart of the matter. Eur Heart J. 2022;43:3332\u20134.","journal-title":"Eur Heart J"},{"key":"6926_CR25","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1161\/HYPERTENSIONAHA.121.16503","volume":"77","author":"K Raby","year":"2021","unstructured":"Raby K, Rocco M, Oparil S, Gilbert ON, Upadhya B. Heart failure primary prevention: what does SPRINT add? Recent advances in hypertension. Hypertension. 2021;77:1804\u201314.","journal-title":"Hypertension"},{"key":"6926_CR26","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s10741-020-09960-w","volume":"26","author":"L Bosch","year":"2021","unstructured":"Bosch L, de Haan JJ, Bastemeijer M, van der Burg J, van der Worp E, Wesseling M, Viola M, Odille C, El Azzouzi H, Pasterkamp G, Sluijter JPG, Wever KE, de Jager SCA. The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis. Heart Fail Rev. 2021;26:1515\u201324.","journal-title":"Heart Fail Rev"},{"key":"6926_CR27","doi-asserted-by":"crossref","unstructured":"Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, Matsuo N, Ichikawa K, Iwasaki K, Naito T, Namba Y, Yoshida M, Sugiyama H, Ito H. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23073587"},{"key":"6926_CR28","doi-asserted-by":"crossref","unstructured":"Ruiz-Velasco A, Zi M, Hille SS, Azam T, Kaur N, Jiang J, Nguyen B, Sekeres K, Binder P, Collins L, Pu F, Xiao H, Guan K, Frey N, Cartwright EJ, M\u00fcller OJ, Wang X, Liu W. Targeting mir128-3p alleviates myocardial insulin resistance and prevents ischemia-induced heart failure. Elife.2020; 9.","DOI":"10.7554\/eLife.54298"},{"key":"6926_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","volume":"18","author":"GM Uddin","year":"2019","unstructured":"Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al Batran R, Pherwani S, Ho KL, Boisvenue J, Karwi QG, Altamimi T, Wishart DS, Dyck JRB, Ussher JR, Oudit GY, Lopaschuk GD. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 2019;18:86.","journal-title":"Cardiovasc Diabetol"},{"key":"6926_CR30","doi-asserted-by":"publisher","first-page":"17927","DOI":"10.1038\/srep17927","volume":"5","author":"F Fu","year":"2015","unstructured":"Fu F, Zhao K, Li J, Xu J, Zhang Y, Liu C, Yang W, Gao C, Li J, Zhang H, Li Y, Cui Q, Wang H, Tao L, Wang J, Quon MJ, Gao F. Direct evidence that myocardial insulin resistance following myocardial ischemia contributes to post-ischemic heart failure. Sci Rep. 2015;5:17927.","journal-title":"Sci Rep"},{"key":"6926_CR31","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2337\/diabetes.53.7.1655","volume":"53","author":"SL Coort","year":"2004","unstructured":"Coort SL, Hasselbaink DM, Koonen DP, Willems J, Coumans WA, Chabowski A, van der Vusse GJ, Bonen A, Glatz JF, Luiken JJ. Enhanced sarcolemmal FAT\/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes. 2004;53:1655\u201363.","journal-title":"Diabetes"},{"key":"6926_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10557-008-6088-9","volume":"22","author":"AN Carley","year":"2008","unstructured":"Carley AN, Severson DL. What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db\/db mice? Cardiovasc Drugs Ther. 2008;22:83\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6926_CR33","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","volume":"50","author":"DM Ouwens","year":"2007","unstructured":"Ouwens DM, Diamant M, Fodor M, Habets DDJ, Pelsers M, El Hasnaoui M, Dang ZC, van den Brom CE, Vlasblom R, Rietdijk A, Boer C, Coort SLM, Glatz JFC, Luiken J. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia. 2007;50:1938\u201348.","journal-title":"Diabetologia"},{"key":"6926_CR34","doi-asserted-by":"publisher","first-page":"e37505","DOI":"10.1371\/journal.pone.0037505","volume":"7","author":"V Garc\u00eda-R\u00faa","year":"2012","unstructured":"Garc\u00eda-R\u00faa V, Otero MF, Lear PV, Rodr\u00edguez-Penas D, Feij\u00f3o-Band\u00edn S, Noguera-Moreno T, Calaza M, \u00c1lvarez-Barredo M, Mosquera-Leal A, Parrington J, Brugada J, Portol\u00e9s M, Rivera M, Gonz\u00e1lez-Juanatey JR, Lago F. Increased expression of fatty-acid and calcium metabolism genes in failing human heart. PLoS One. 2012;7:e37505.","journal-title":"PLoS ONE"},{"key":"6926_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/jmcc.1996.0257","volume":"29","author":"T Tanaka","year":"1997","unstructured":"Tanaka T, Sohmiya K, Kawamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol. 1997;29:121\u20137.","journal-title":"J Mol Cell Cardiol"},{"key":"6926_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1291\/hypres.26.829","volume":"26","author":"M Iemitsu","year":"2003","unstructured":"Iemitsu M, Miyauchi T, Maeda S, Sakai S, Fujii N, Miyazaki H, Kakinuma Y, Matsuda M, Yamaguchi I. Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res. 2003;26:829\u201337.","journal-title":"Hypertens Res"},{"key":"6926_CR37","doi-asserted-by":"publisher","first-page":"E618","DOI":"10.1152\/ajpendo.00106.2011","volume":"301","author":"LK Steinbusch","year":"2011","unstructured":"Steinbusch LK, Luiken JJ, Vlasblom R, Chabowski A, Hoebers NT, Coumans WA, Vroegrijk IO, Voshol PJ, Ouwens DM, Glatz JF, Diamant M. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. Am J Physiol Endocrinol Metab. 2011;301:E618\u201327.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6926_CR38","doi-asserted-by":"publisher","first-page":"H552","DOI":"10.1152\/ajpheart.00626.2016","volume":"312","author":"MM Sung","year":"2017","unstructured":"Sung MM, Byrne NJ, Kim TT, Levasseur J, Masson G, Boisvenue JJ, Febbraio M, Dyck JR. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure. Am J Physiol Heart Circ Physiol. 2017;312:H552\u201360.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6926_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1536\/ihj.18-114","volume":"60","author":"K Nakatani","year":"2019","unstructured":"Nakatani K, Masuda D, Kobayashi T, Sairyo M, Zhu Y, Okada T, Naito AT, Ohama T, Koseki M, Oka T, Akazawa H, Nishida M, Komuro I, Sakata Y, Yamashita S. Pressure overload impairs cardiac function in long-chain fatty acid transporter CD36-knockout mice. Int Heart J. 2019;60:159\u201367.","journal-title":"Int Heart J"},{"key":"6926_CR40","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1038\/s41598-018-30616-1","volume":"8","author":"Y Umbarawan","year":"2018","unstructured":"Umbarawan Y, Syamsunarno M, Koitabashi N, Obinata H, Yamaguchi A, Hanaoka H, Hishiki T, Hayakawa N, Sano M, Sunaga H, Matsui H, Tsushima Y, Suematsu M, Kurabayashi M, Iso T. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure. Sci Rep. 2018;8:12035.","journal-title":"Sci Rep"},{"key":"6926_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.7150\/ijms.107224","volume":"22","author":"J Geng","year":"2025","unstructured":"Geng J, Zhang X, Wang Y, Guo D, Liu P, Pu S, Yang X, Liang Q, Chang P, Li T, Hu L, Guo Y. CD36 knockdown attenuates pressure overload-induced cardiac injury by preventing lipotoxicity and improving myocardial energy metabolism. Int J Med Sci. 2025;22:1223\u201336.","journal-title":"Int J Med Sci"},{"key":"6926_CR42","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1038\/s41467-024-48970-2","volume":"15","author":"YL Ma","year":"2024","unstructured":"Ma YL, Kong CY, Guo Z, Wang MY, Wang P, Liu FY, Yang D, Yang Z, Tang QZ. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5\/NR4a1 axis. Nat Commun. 2024;15:4757.","journal-title":"Nat Commun"},{"key":"6926_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/CIRCULATIONAHA.123.066542","volume":"149","author":"W Xu","year":"2024","unstructured":"Xu W, Billon C, Li H, Wilderman A, Qi L, Graves A, Rideb J, Zhao Y, Hayes M, Yu K, Losby M, Hampton CS, Adeyemi CM, Hong SJ, Nasiotis E, Fu C, Oh TG, Fan W, Downes M, Welch RD, Evans RM, Milosavljevic A, Walker JK, Jensen BC, Pei L, Burris T, Zhang L. Novel Pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function. Circulation. 2024;149:227\u201350.","journal-title":"Circulation"},{"key":"6926_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature26153","volume":"556","author":"G Scapin","year":"2018","unstructured":"Scapin G, Dandey VP, Zhang Z, Prosise W, Hruza A, Kelly T, Mayhood T, Strickland C, Potter CS, Carragher B. Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis. Nature. 2018;556:122\u20135.","journal-title":"Nature"},{"key":"6926_CR45","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4314\/ovj.v10i4.2","volume":"10","author":"OD Arkadievich","year":"2021","unstructured":"Arkadievich OD. Metabolic markers of myocardium insulin resistance in dogs with heart failure. Open Vet J. 2021;10:363\u201370.","journal-title":"Open Vet J"},{"key":"6926_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s12967-023-04288-z","volume":"21","author":"M Huang","year":"2023","unstructured":"Huang M, Chen L, Guo Y, Ruan Y, Xu H. PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer. J Transl Med. 2023;21:445.","journal-title":"J Transl Med"},{"key":"6926_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12967-024-04880-x","volume":"22","author":"L Longhitano","year":"2024","unstructured":"Longhitano L, Distefano A, Musso N, Bonacci P, Orlando L, Giallongo S, Tibullo D, Denaro S, Lazzarino G, Ferrigno J, Nicolosi A, Alanazi AM, Salomone F, Tropea E, Barbagallo IA, Bramanti V, Li Volti G, Lazzarino G, Torella D, Amorini AM. (+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease. J Transl Med. 2024;22:82.","journal-title":"J Transl Med"},{"key":"6926_CR48","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/j.bbadis.2019.06.017","volume":"1865","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Yang J, Chen H, Li J, Que L, Zhu G, Liu L, Ha T, Chen Q, Li C, Xu Y, Li Y. Peli1 induction impairs cardiac microvascular endothelium through Hsp90 dissociation from IRE1\u03b1. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2606\u201317.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6926_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yjmcc.2018.08.016","volume":"123","author":"RA C\u00e1ceres","year":"2018","unstructured":"C\u00e1ceres RA, Chavez T, Maestro D, Palanca AR, Bolado P, Madrazo F, Aires A, Cortajarena AL, Villar AV. Reduction of cardiac TGF\u03b2-mediated profibrotic events by Inhibition of Hsp90 with engineered protein. J Mol Cell Cardiol. 2018;123:75\u201387.","journal-title":"J Mol Cell Cardiol"},{"key":"6926_CR50","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.119.315833","volume":"125","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yang M, Huang W, Chen W, Zhao Y, Schulte ML, Volberding P, Gerbec Z, Zimmermann MT, Zeighami A, Demos W, Zhang J, Knaack DA, Smith BC, Cui W, Malarkannan S, Sodhi K, Shapiro JI, Xie Z, Sahoo D, Silverstein RL. Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses. Circ Res. 2019;125:1087\u2013102.","journal-title":"Circ Res"},{"key":"6926_CR51","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada P, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C, Valverde \u00c1M. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 2020;11:802.","journal-title":"Cell Death Dis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06926-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:26:48Z","timestamp":1757345208000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6926"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06926-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Tongji Hospital, Tongji Medical College Ethics Review Committee, and the Chinese Clinical Trial Registration Center (ChiCTR2500099708), which conforms to the principles outlined in the Helsinki Declaration, and obtained the informed consent of all subjects\u2019 family members before the start of the program. Animal experiments in this study conformed to the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (NIH Publication No. 85-23, revised 2011). All experimental protocols were approved by the Experimental Animal Research Committee of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"870"}}